大葉大學圖書館 |

Apolipoprotein mimetics in the management of human disease[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	572.6
書名/作者:	Apolipoprotein mimetics in the management of human disease/ edited by G.M. Anantharamaiah, Dennis Goldberg.
其他作者:	Anantharamaiah, G.M.
出版者:	Cham : : Springer International Publishing :, 2015.
面頁冊數:	xxi, 182 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Apolipoproteins.
標題:	High density lipoproteins.
標題:	Peptides.
標題:	Lipids - Metabolism.
標題:	Medicine & Public Health.
標題:	Medical Biochemistry.
標題:	Cardiology.
標題:	Medicine/Public Health, general.
ISBN:	9783319173504 (electronic bk.)
ISBN:	9783319173498 (paper)
內容註:	1. HDL and the Amphipathic Helix -- 2. ApoA-I mimetic peptides: A review of the present status -- 3. Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux -- 4. ApoA-I Mimetic Peptides and Diabetes -- 5. Apolipoprotein A-I mimetic peptides in Mouse Models of Cancer -- 6. Effects of ApoA-I mimetic peptide L-4F in LPS-mediated inflammation -- 7. Apolipoprotein mimetics in the amelioration of respiratory inflammation -- 8. Regulation of Macrophage Polarity by HDL, Apolipoproteins And Apolipoprotein Mimetic Peptides -- 9. Apolipoprotein E & Atherosclerosis: Beyond Lipid Effects -- 10. Apolipoprotein E mimetic peptides - Cholesterol dependent and independent properties -- 11. Apolipoprotein-E and Mimetics as Targets and Therapeutics for Alzheimer's Disease.
摘要、提要註:	This comprehensive book provides not only the stages in the development of this unique and specialized field but also updates on the current state of research and development of apolipoprotein mimetics as therapeutic modalities for various lipid-mediated disorders. The book consists of 11 chapters all written by leading scientists from well-reputed laboratories in the USA. After an introduction by Dr. Godfrey Getz, Professor of Medicine at the University of Chicago and the Associate Editor of the Journal Lipid Research, the book presents a narration of how a theory can lead to the discovery of treatment modalities to several devastating diseases such as diabetes, Alzheimer's disease, arthritis; asthma; atherosclerosis, chronic rejection of transplanted hearts and cancer. Present therapies for most of these diseases are not adequate. Using the models of two long anti-atherogenic and anti-inflammatory proteins (apolipoprotein A-I and apolipoprotein E with 243 and 299 amino acids, respectively) short mimetic peptides of 18 to 28 amino acid residues in length, which can be produced either synthetically or genetically in edible fruits and vegetables, have been shown to exert profound biological effects in a large number of animal models of diseases. The book also presents novel ideas, highly unexpected mechanisms of action in animal models and even in initial clinical studies in humans, which can lead to additional improvements in basic and clinical research in biological science. All the chapters are written by experts in their respective fields who have contributed immensely to the literature. This is the first compendium of this growing field presented in the form of a book.
電子資源:	http://dx.doi.org/10.1007/978-3-319-17350-4

Apolipoprotein mimetics in the management of human disease[electronic resource] /
Apolipoprotein mimetics in the management of human disease[electronic resource] /edited by G.M. Anantharamaiah, Dennis Goldberg. - Cham :Springer International Publishing :2015. - xxi, 182 p. :ill., digital ;24 cm.

1. HDL and the Amphipathic Helix -- 2. ApoA-I mimetic peptides: A review of the present status -- 3. Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux -- 4. ApoA-I Mimetic Peptides and Diabetes -- 5. Apolipoprotein A-I mimetic peptides in Mouse Models of Cancer -- 6. Effects of ApoA-I mimetic peptide L-4F in LPS-mediated inflammation -- 7. Apolipoprotein mimetics in the amelioration of respiratory inflammation -- 8. Regulation of Macrophage Polarity by HDL, Apolipoproteins And Apolipoprotein Mimetic Peptides -- 9. Apolipoprotein E & Atherosclerosis: Beyond Lipid Effects -- 10. Apolipoprotein E mimetic peptides - Cholesterol dependent and independent properties -- 11. Apolipoprotein-E and Mimetics as Targets and Therapeutics for Alzheimer's Disease.

This comprehensive book provides not only the stages in the development of this unique and specialized field but also updates on the current state of research and development of apolipoprotein mimetics as therapeutic modalities for various lipid-mediated disorders. The book consists of 11 chapters all written by leading scientists from well-reputed laboratories in the USA. After an introduction by Dr. Godfrey Getz, Professor of Medicine at the University of Chicago and the Associate Editor of the Journal Lipid Research, the book presents a narration of how a theory can lead to the discovery of treatment modalities to several devastating diseases such as diabetes, Alzheimer's disease, arthritis; asthma; atherosclerosis, chronic rejection of transplanted hearts and cancer. Present therapies for most of these diseases are not adequate. Using the models of two long anti-atherogenic and anti-inflammatory proteins (apolipoprotein A-I and apolipoprotein E with 243 and 299 amino acids, respectively) short mimetic peptides of 18 to 28 amino acid residues in length, which can be produced either synthetically or genetically in edible fruits and vegetables, have been shown to exert profound biological effects in a large number of animal models of diseases. The book also presents novel ideas, highly unexpected mechanisms of action in animal models and even in initial clinical studies in humans, which can lead to additional improvements in basic and clinical research in biological science. All the chapters are written by experts in their respective fields who have contributed immensely to the literature. This is the first compendium of this growing field presented in the form of a book.

ISBN: 9783319173504 (electronic bk.)

Standard No.: 10.1007/978-3-319-17350-4doiSubjects--Topical Terms:

627708
Apolipoproteins.

LC Class. No.: QP99.3.A65

Dewey Class. No.: 572.6

Apolipoprotein mimetics in the management of human disease[electronic resource] /
LDR:03428nam a2200313 a 4500 001 439594
003 DE-He213
005 20160125150151.0
006 m d
007 cr nn 008maaau
008 160322s2015 gw s 0 eng d
020 $a 9783319173504 (electronic bk.)
020 $a 9783319173498 (paper)
024 7 $a 10.1007/978-3-319-17350-4 $2 doi
035 $a 978-3-319-17350-4
040 $a GP $c GP
041 0 $a eng
050 4 $a QP99.3.A65
072 7 $a PSB $2 bicssc
072 7 $a MED008000 $2 bisacsh
082 0 4 $a 572.6 $2 23
090 $a QP99.3.A65 $b A643 2015
245 0 0 $a Apolipoprotein mimetics in the management of human disease $h [electronic resource] / $c edited by G.M. Anantharamaiah, Dennis Goldberg.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2015.
300 $a xxi, 182 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. HDL and the Amphipathic Helix -- 2. ApoA-I mimetic peptides: A review of the present status -- 3. Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux -- 4. ApoA-I Mimetic Peptides and Diabetes -- 5. Apolipoprotein A-I mimetic peptides in Mouse Models of Cancer -- 6. Effects of ApoA-I mimetic peptide L-4F in LPS-mediated inflammation -- 7. Apolipoprotein mimetics in the amelioration of respiratory inflammation -- 8. Regulation of Macrophage Polarity by HDL, Apolipoproteins And Apolipoprotein Mimetic Peptides -- 9. Apolipoprotein E & Atherosclerosis: Beyond Lipid Effects -- 10. Apolipoprotein E mimetic peptides - Cholesterol dependent and independent properties -- 11. Apolipoprotein-E and Mimetics as Targets and Therapeutics for Alzheimer's Disease.
520 $a This comprehensive book provides not only the stages in the development of this unique and specialized field but also updates on the current state of research and development of apolipoprotein mimetics as therapeutic modalities for various lipid-mediated disorders. The book consists of 11 chapters all written by leading scientists from well-reputed laboratories in the USA. After an introduction by Dr. Godfrey Getz, Professor of Medicine at the University of Chicago and the Associate Editor of the Journal Lipid Research, the book presents a narration of how a theory can lead to the discovery of treatment modalities to several devastating diseases such as diabetes, Alzheimer's disease, arthritis; asthma; atherosclerosis, chronic rejection of transplanted hearts and cancer. Present therapies for most of these diseases are not adequate. Using the models of two long anti-atherogenic and anti-inflammatory proteins (apolipoprotein A-I and apolipoprotein E with 243 and 299 amino acids, respectively) short mimetic peptides of 18 to 28 amino acid residues in length, which can be produced either synthetically or genetically in edible fruits and vegetables, have been shown to exert profound biological effects in a large number of animal models of diseases. The book also presents novel ideas, highly unexpected mechanisms of action in animal models and even in initial clinical studies in humans, which can lead to additional improvements in basic and clinical research in biological science. All the chapters are written by experts in their respective fields who have contributed immensely to the literature. This is the first compendium of this growing field presented in the form of a book.
650 0 $a Apolipoproteins. $3 627708
650 0 $a High density lipoproteins. $3 605161
650 0 $a Peptides. $3 428034
650 0 $a Lipids $x Metabolism. $3 416406
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Medical Biochemistry. $3 463462
650 2 4 $a Cardiology. $3 189244
650 2 4 $a Medicine/Public Health, general. $3 463494
700 1 $a Anantharamaiah, G.M. $3 627706
700 1 $a Goldberg, Dennis. $3 627707
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17350-4
950 $a Medicine (Springer-11650)